8.1 Expiration Date Interpretation and Multi-Dose Vial Beyond-Use Dating (BUD)
Key Takeaways
- A manufacturer expiration date in 'EXP MM/YYYY' format remains legally and clinically valid through the VERY LAST DAY of that stated month (e.g., EXP 10/2026 expires at 11:59 PM on October 31, 2026; EXP 02/2026 expires on February 28, 2026).
- A Beyond-Use Date (BUD) is the calculated date and time after which a compounded, repackaged, or opened commercial drug product must not be used, and it can NEVER exceed the manufacturer's sealed expiration date.
- Under USP <797> and CDC guidelines, preserved Multi-Dose Vials (MDVs) have a default Beyond-Use Date of 28 days post-puncture unless the manufacturer package insert explicitly specifies a different duration.
- Single-Dose Vials (SDVs) and ampules lack antimicrobial preservatives; they must be discarded immediately if opened in air quality worse than ISO Class 5, or within 12 hours if punctured inside an ISO Class 5 primary engineering control.
- Reconstituted oral antibiotic suspensions carry distinct post-reconstitution BUDs and storage requirements (e.g., Augmentin 10 days refrigerated, Amoxicillin 14 days refrigerated or room temp, Cefdinir 10 days room temp only, Biaxin and Cleocin 14 days room temp only).
Expiration Date Interpretation and Multi-Dose Vial Beyond-Use Dating (BUD)
Core Verification Rule: During technical product verification, a pharmacy technician must independently verify that every dispensed medication retains full chemical potency, physical stability, and microbiological sterility throughout the patient's entire prescribed course of therapy. The technician must enforce the 'Last Day of the Month' rule for manufacturer expiration dates, calculate post-puncture Beyond-Use Dates (BUDs) for multi-dose vials, and ensure single-dose vials are never reused.
Ensuring medication stability and sterility is a fundamental responsibility in product verification. Dispensing an expired or compromised drug product can lead to subtherapeutic clinical outcomes, toxic degradation byproducts, or life-threatening systemic infections from microbial contamination.
1. Manufacturer Expiration Date vs. Beyond-Use Date (BUD)
In pharmacy practice and regulatory compliance, a critical legal and clinical distinction exists between a Manufacturer Expiration Date and a Beyond-Use Date (BUD).
┌────────────────────────────────────────────────────────────────────────┐
│ EXPIRATION DATE VS. BEYOND-USE DATE │
├────────────────────────────────────────────────────────────────────────┤
│ MANUFACTURER EXPIRATION DATE │
│ • Determined by the pharmaceutical manufacturer through extensive │
│ FDA-mandated stability, kinetic, and degradation testing. │
│ • Guarantees >= 90% active drug potency and purity in the original, │
│ unopened, sealed container stored under labeled storage conditions. │
│ │
│ BEYOND-USE DATE (BUD) │
│ • Assigned by pharmacy personnel when a drug product is opened, │
│ reconstituted, repackaged, or compounded into a customized dose. │
│ • Identifies the date (and time, if applicable) after which the │
│ preparation MUST NOT be used, administered, or dispensed. │
│ • Golden Rule: A BUD can NEVER exceed the manufacturer's exp date! │
└────────────────────────────────────────────────────────────────────────┘
The 'Last Day of the Month' Rule (EXP MM/YYYY)
When a manufacturer expiration date displays only a month and a four-digit year (or two-digit year), United States Pharmacopeia (USP) general notices establish that the product remains valid through the very last day of that stated month at 11:59 PM.
| Stated Container Date | Interpreted Expiration Date | Calendar Calculation Rule |
|---|---|---|
EXP 10/2026 (or 10/26) | October 31, 2026 | October has 31 calendar days; valid through midnight Oct 31 |
| EXP 02/2026 | February 28, 2026 | Non-leap year; valid through midnight Feb 28 |
| EXP 02/2028 | February 29, 2028 | Leap year; valid through midnight Feb 29 |
| EXP 04/2027 | April 30, 2027 | April has 30 calendar days; valid through midnight April 30 |
| EXP 09/15/2026 | September 15, 2026 | Exact date format (MM/DD/YYYY); valid only through stated day |
[!IMPORTANT] The Days Supply Expiration Checkpoint: During TPV checking, the verifying technician must compare the calculated completion date of the prescription against the product's expiration date. If a 90-day maintenance prescription is filled on September 15, 2026, the therapy extends through December 14, 2026. Dispensing a stock bottle labeled
EXP 10/2026(expires October 31, 2026) is a major dispensing error because the medication will expire 44 days before the patient finishes the supply.
2. Multi-Dose Vials (MDV) Post-Puncture Dating
A Multi-Dose Vial (MDV) is a liquid parenteral container equipped with a rubber septum designed for multiple needle punctures to withdraw individual patient doses. MDVs contain antimicrobial preservatives (such as benzyl alcohol, phenol, meta-cresol, or methylparaben) to inhibit bacterial and fungal growth introduced during repeated entries.
┌────────────────────────────────────────────────────────────────────────┐
│ USP <797> & CDC 28-DAY MDV RULE │
├────────────────────────────────────────────────────────────────────────┤
│ Standard Rule: An opened or punctured Multi-Dose Vial has a maximum │
│ Beyond-Use Date of 28 DAYS, unless the manufacturer explicitly │
│ specifies a different duration in the official package insert. │
│ │
│ Verification Math: BUD = Puncture Date + 28 Days │
│ (Or Manufacturer Expiration Date, whichever occurs FIRST!) │
└────────────────────────────────────────────────────────────────────────┘
Comparing MDV Beyond-Use Dating Rules
| Product / Medication Type | Post-Puncture BUD Standard | Storage Requirement | Key Clinical / Verification Note |
|---|---|---|---|
| Standard Preserved MDV (e.g., Heparin, Lidocaine MDV) | 28 Days | Controlled Room Temp or Refrigerator (per label) | USP <797> default rule post-puncture |
| Bacteriostatic Water / 0.9% NaCl MDV | 28 Days | Controlled Room Temp (20 degrees Celsius to 25 degrees Celsius) | Never use in neonates (benzyl alcohol toxicity) |
| Insulin Vials (e.g., Humalog, Novolog, Lantus) | 28 Days | Room Temperature (up to 25 degrees Celsius / 30 degrees Celsius) | Discard after 28 days of room temp use |
| Insulin Detemir (Levemir) Vial / Pen | 42 Days | Room Temperature (up to 30 degrees Celsius) | Manufacturer-extended stability exception |
| Insulin Degludec (Tresiba) Vial / Pen | 56 Days (8 Weeks) | Room Temperature (up to 30 degrees Celsius) | Manufacturer-extended stability exception |
| Multi-Dose Influenza Vaccines (Fluzone MDV) | 28 Days | Refrigerator (2 degrees Celsius to 8 degrees Celsius) | Must record first puncture date on vial label |
| COVID-19 Multi-Dose Vials (e.g., Pfizer/Moderna) | 6 to 12 Hours (per specific EUA/insert) | Refrigerator or Room Temp (per insert) | Extremely short stability post-dilution/puncture |
The Earlier Date Rule Trajectory
When calculating the BUD of an opened multi-dose vial, the verifying technician must compare the 28-day post-puncture date against the manufacturer's sealed container expiration date:
Effective BUD = Earliest of (Puncture Date + 28 Days) OR Manufacturer Expiration Date
- Scenario A: An MDV with manufacturer
EXP 12/2027is punctured on October 1, 2026. Puncture date + 28 days = October 29, 2026. The manufacturer date is far in the future, so the BUD is October 29, 2026. - Scenario B: An MDV with manufacturer
EXP 10/15/2026is punctured on October 1, 2026. Puncture date + 28 days would be October 29, 2026. However, the manufacturer expiration date is October 15, 2026. The vial MUST be discarded on October 15, 2026.
[!CAUTION] Mandatory MDV Septum Labeling: Every opened multi-dose vial in a pharmacy, cleanroom, clinic, or automated dispensing cabinet (ADC) must display a secure auxiliary label containing: (1) Date of first puncture, (2) Calculated Beyond-Use Date, and (3) Initials of the technician who accessed the vial. Any unlabelled, punctured MDV found without a documented puncture date must be quarantined and discarded immediately.
3. Single-Dose Vials (SDV) vs. Multi-Dose Vials (MDV)
A Single-Dose Vial (SDV) (or single-use vial / glass ampule / prefilled syringe) is formulated without antimicrobial preservatives. It is designed for single-patient administration as a single entry.
┌────────────────────────────────────────────────────────────────────────┐
│ USP <797> SINGLE-DOSE VIAL (SDV) RULES │
├────────────────────────────────────────────────────────────────────────┤
│ 1. OPENED IN AIR WORSE THAN ISO CLASS 5 (e.g., clinic room, bedside): │
│ • Must be used IMMEDIATELY for a single patient. │
│ • Any remaining drug volume must be DISCARDED immediately! │
│ • Maximum storage: 1 hour post-puncture if not used immediately. │
│ │
│ 2. OPENED IN ISO CLASS 5 AIR (inside laminar flow hood or PEC): │
│ • May be accessed for multiple compounding entries up to 12 HOURS │
│ within the same ISO Class 5 hood environment. │
│ • Once removed from ISO Class 5 air, it must be discarded. │
│ │
│ 3. GLASS AMPULES: │
│ • Must NEVER be stored for any duration once broken open. │
│ • Must be used immediately with a 5-micron filter needle/straw │
│ and discarded immediately regardless of ISO environment. │
└────────────────────────────────────────────────────────────────────────┘
| Parameter | Multi-Dose Vial (MDV) | Single-Dose Vial (SDV) | Glass Ampule |
|---|---|---|---|
| Antimicrobial Preservatives | Present (e.g., benzyl alcohol) | None (Preservative-Free) | None (Preservative-Free) |
| Intended Use | Multiple entries / multiple patients | Single entry / single patient | Single entry / single patient |
| Opened in < ISO 5 Air | 28 days (with date label) | Discard immediately (max 1 hr) | Discard immediately |
| Opened in ISO 5 Air | 28 days (or package insert) | Maximum 12 hours | Discard immediately |
| Storage of Leftover Volume | Permitted if labeled and unexpired | Strictly Prohibited | Strictly Prohibited |
4. Post-Reconstitution Beyond-Use Dating for Oral Liquids
Many oral antimicrobial liquids are manufactured as dry powders to maintain chemical stability on pharmacy shelves. Once reconstituted with purified (distilled) water, the active antibiotic molecule undergoes gradual hydrolytic degradation.
Verifying technicians must memorize the exact post-reconstitution BUD and storage conditions for standard oral antibiotic suspensions, as storage temperature errors directly accelerate chemical inactivation or physical breakdown.
┌────────────────────────────────────────────────────────────────────────┐
│ COMMON ORAL SUSPENSION RECONSTITUTION STABILITY │
├────────────────────────────────────────────────────────────────────────┤
│ REFRIGERATION MANDATORY (2 degrees Celsius to 8 degrees Celsius): │
│ • Augmentin (Amoxicillin/Clavulanate): 10 Days (Rapid clavulanate loss)│
│ • Cephalexin (Keflex): 14 Days │
│ • Cefprozil (Cefzil): 14 Days │
│ • Penicillin V Potassium (Pen VK): 14 Days │
│ │
│ ROOM TEMPERATURE ONLY (DO NOT REFRIGERATE): │
│ • Cefdinir (Omnicef): 10 Days (Refrigeration causes thick gel/clump) │
│ • Azithromycin (Zithromax): 10 Days │
│ • Clarithromycin (Biaxin): 14 Days (Refrigeration causes bitter taste)│
│ • Clindamycin (Cleocin): 14 Days (Refrigeration thickens liquid) │
│ │
│ REFRIGERATION PREFERRED / ROOM TEMP PERMITTED: │
│ • Amoxicillin (Amoxil): 14 Days (Refrigeration improves taste) │
│ • Cefuroxime axetil (Ceftin): 10 Days (Refrigeration required) │
└────────────────────────────────────────────────────────────────────────┘
High-Yield Reconstitution Verification Matrix
| Generic Name | Brand Name | Reconstituted BUD | Mandated Storage Condition | Verification & Clinical Hazard |
|---|---|---|---|---|
| Amoxicillin / Clavulanate | Augmentin | 10 Days | Refrigerate (2 degrees Celsius to 8 degrees Celsius) | Must be refrigerated; clavulanic acid hydrolyzes rapidly at room temperature. |
| Amoxicillin | Amoxil | 14 Days | Refrigerate Preferred (Room temp stable) | Stable at room temp, but refrigeration preserves palatability for pediatric patients. |
| Cefdinir | Omnicef | 10 Days | Room Temperature (20 degrees Celsius to 25 degrees Celsius) | DO NOT REFRIGERATE; cold temperatures cause excessive viscosity and irreversible gelling. |
| Clarithromycin | Biaxin | 14 Days | Room Temperature (20 degrees Celsius to 25 degrees Celsius) | DO NOT REFRIGERATE; cold precipitates the active drug and causes extreme bitterness. |
| Azithromycin | Zithromax | 10 Days | Room Temperature (20 degrees Celsius to 25 degrees Celsius) | Store at controlled room temperature. |
| Cephalexin | Keflex | 14 Days | Refrigerate (2 degrees Celsius to 8 degrees Celsius) | Mandatory refrigeration auxiliary label. |
| Cefprozil | Cefzil | 14 Days | Refrigerate (2 degrees Celsius to 8 degrees Celsius) | Mandatory refrigeration auxiliary label. |
| Penicillin V Potassium | Pen VK | 14 Days | Refrigerate (2 degrees Celsius to 8 degrees Celsius) | Mandatory refrigeration auxiliary label. |
| Clindamycin Oral Solution | Cleocin Pediatric | 14 Days (2 Weeks) | Room Temperature (20 degrees Celsius to 25 degrees Celsius) | DO NOT REFRIGERATE; chilling causes thick crystallization. |
| Ciprofloxacin Suspension | Cipro | 14 Days | Room Temperature (20 degrees Celsius to 25 degrees Celsius) | Microcapsule suspension; do not refrigerate or freeze. |
A technician is verifying a 30-day supply of a maintenance medication on August 10, 2026. The stock bottle selected from the pharmacy shelf displays a manufacturer expiration date of 'EXP 08/2026'. Which of the following statements correctly evaluates the validity of this stock bottle for this prescription?
On October 10, 2026, a pharmacy technician opens and punctures a new 10 mL Multi-Dose Vial (MDV) of Bacteriostatic 0.9% Sodium Chloride Injection. The manufacturer stock container displays an expiration date of 'EXP 10/25/2026'. According to USP <797> guidelines, what Beyond-Use Date (BUD) must be affixed to this opened vial?
A certified technician is conducting product verification in an outpatient infusion clinic. A nurse opened a 50 mL Single-Dose Vial (SDV) of preservative-free vancomycin in an ambient treatment room (< ISO Class 5 air) 3 hours ago to draw up a partial dose. The nurse placed the remaining 20 mL vial in the medication refrigerator for a later patient. How should the verifying technician handle this vial?
A technician is verifying two reconstituted oral suspension prescriptions: Amoxicillin/Clavulanate (Augmentin) 400 mg/5 mL and Cefdinir (Omnicef) 250 mg/5 mL. Which auxiliary labeling and Beyond-Use Dating combination is correct?